切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2018, Vol. 14 ›› Issue (06) : 740 -744. doi: 10.3877/cma.j.issn.1673-5250.2018.06.019

所属专题: 文献

综述

产后出血的病因、诊断及治疗研究进展
吴雅娟1, 单委1   
  1. 1. 225001 江苏,扬州大学临床医学院
  • 收稿日期:2018-04-09 修回日期:2018-10-28 出版日期:2018-12-01

Research progress of etiology, diagnosis and treatment of postpartum hemorrhage

Yajuan Wu1, Wei Shan1   

  1. 1. Medical College of Yangzhou University, Yangzhou 225001, Jiangsu Province, China
  • Received:2018-04-09 Revised:2018-10-28 Published:2018-12-01
  • About author:
    Corresponding author: Lu Dan, Email:
  • Supported by:
    Scientific Research Fund of Maternal and Child Health of Jiangsu Provincial Commission of Health and Family Planning(F201663)
引用本文:

吴雅娟, 单委. 产后出血的病因、诊断及治疗研究进展[J/OL]. 中华妇幼临床医学杂志(电子版), 2018, 14(06): 740-744.

Yajuan Wu, Wei Shan. Research progress of etiology, diagnosis and treatment of postpartum hemorrhage[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2018, 14(06): 740-744.

产后出血(PPH)是分娩期严重并发症,其中由于子宫收缩乏力所致PPH最为常见。近年胎盘因素,如前置胎盘、胎盘植入等发生率呈逐年增高趋势,从而导致PPH发生率增加。前置胎盘、胎盘植入等可采用多种辅助检查手段(超声、MRI、膀胱镜)尽早确诊,评估病情,制定个体化治疗方案,从而降低PPH发生率。最新研究认为,国家全面两孩政策开放及剖宫产术后再次妊娠选择经阴道分娩,可能增加胎盘因素引起的PPH发生率。临床对于PPH的诊断,不仅应依据分娩时的失血量,还需重视产妇血流动力学改变。目前采用药物治疗、手术治疗、介入治疗等PPH个体化治疗策略,均取得较好临床疗效。笔者拟就PPH的病因、诊断及治疗的最新研究进展,进行综述如下。

Postpartum hemorrhage (PPH) is a serious complication during delivery, and PPH caused by uterine contraction fatigue is the most common kind of PPH. In recent years, the incidence of placenta factors, such as of placenta previa and placenta increta, has been increasing year by year, resulting an increase in the incidence of PPH which can be diagnosed as early as possible via varieties of auxiliary examination means (ultrasound, MRI, cystoscope), to evaluate the pathogenetic conditions and develop individualized therapy strategies, thereby reducing the incidence of PPH. Recent studies on the pathogenesis of PPH suggest that the Universal Two-Child Policy in China and choice of vaginal delivery after cesarean section may increase the incidence of PPH caused by placental factors. For the diagnosis of PPH, the most recent method is not only based on the volume of blood loss during delivery, but also on hemodynamic changes. Currently, the individualized treatment of PPH with strategies of drug therapy, surgical treatment and interventional therapy have achieved good clinical efficacy. The article focuses on the latest advances in etiology, diagnosis and treatment of PPH.

[1]
谢幸, 苟文丽. 妇产科学[M]. 8版. 北京:人民卫生出版,2013: 211-215 .
[2]
陆红梅,张卫社. 产妇产后出血影响因素调查及综合护理对策[J]. 中国现代医生,2013, 51(33): 47-49.
[3]
Mavrides E, Allard S, Chandraharan E, et al. Royal College of Physicians: prevention and management of postpartum hemorrhage[J]. Br J Obstet Gynaecol, 2017, 124(5): e106-e149.
[4]
Committee on Practice Bulletins-Obstetrics. Practice bulletins No.183: postpartum hemorrhage[J]. Obstet Gynecol, 2017, 130(4): e168-e186.
[5]
李春凤. 产后出血的相关因素及治疗进展[J]. 医学信息,2015, 28(19): 358.
[6]
Talaulikar VS, Arulkumaran S. Vaginal birth after cesarean[J]. Obstet Gynecol Reprod Med, 2015, 25(7): 195-202.
[7]
吕斌,陈锰,刘兴会. 前置胎盘孕妇围产期行子宫切除术的危险因素分析[J].中华妇产科杂志,2016, 51(7): 498-502.
[8]
de la Cruz CZ, Thompson EL, O′Rourke K, et al. Cesarean section and the risk of emergency peripartum hysterectomy in high-income countries: a systematic review[J]. Arch Gynecol Obstet, 2015, 292(6): 1201-1215.
[9]
陈东. 产后出血及其临床救治探析[J]. 大家健康(学术版), 2015, 9(20): 191.
[10]
Winikoff B, Dabash R, Durocher J, et al Treatment of postpartum hemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial[J]. Lancet, 2010, 375(9710): 210-216.
[11]
朱恢玫. 催产素与米索前列醇治疗产后出血的临床效果评价[J]. 临床医学研究与实践,2016, 1(21): 17-19.
[12]
刘兴会,张力,张静. 《产后出血预防与处理指南(草案)》(2009)及《产后出血预防与处理指南(2014年版)》解读[J/CD]. 中华妇幼临床医学杂志(电子版), 2015, 11(4): 433-447.
[13]
Jin B, Du YM, Zhang FB, et al. Carbetocin for the prevention of postpartum hemorrhage: a systematic review and Meta-analysis of randomized controlled trials [J]. J Matern Fetal Neonatal Med, 2016, 29(3): 400-407.
[14]
曾成英,万波,郭遂群,等. Bakri球囊填塞与B-Lynch缝合治疗剖宫产术后产后出血的疗效比较[J]. 实用妇产科杂志,2016, 32(6): 472-474.
[15]
韦献琼,马刚. 子宫收缩乏力性产后出血的病因及治疗进展[J]. 中国临床新医学,2010, 3(11): 1148-1150.
[16]
同芙菊,郭丹凤,李悦,等. 产后出血的治疗研究进展[J]. 中国妇幼保健,2017, 32(6): 1336-1338.
[17]
梁媚珍,唐莉,文思敏,等. 凶险型前置胎盘诊治进展[J]. 中国医学创新,2015, 12(12): 153-156.
[18]
朱晓童,孔祥,郑英. 介入治疗在前置胎盘合并胎盘植入剖宫产分娩中应用的研究进展[J/CD] . 中华妇幼临床医学杂志(电子版), 2017, 13(2): 240-243.
[19]
王利民,罗丹,周辉,等. 动脉序贯介入治疗对凶险型前置胎盘的疗效评价[J]. 现代妇产科进展,2015, 24(11): 823-827.
[20]
Woman Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN) : an international, randomised, double-blind, placebo-controlled trial[J]. Lancet, 2017, 389(10084): 2105-2116.
[21]
Silver RM. Abnormal placentation: placenta previa, vasa previa, and placenta accrete[J]. Obstet Gynecol, 2015, 126(3): 654-668.
[22]
D′Arpe S, Franceschetti S, Corosu R, et al. Emergency peripartum hysterectomy in a tertiary teaching hospital: a 14-year review[J]. Arch Gynecol Obstet, 2015, 291(4): 841-847.
[23]
Temizkan O, Ang1n D, Karaku R, et al. Changing trends in emergency peripartum hysterectomy in a tertiary obstetric center in Turkey during 2000-2013[J]. J Turk Ger Gynecol Assoc, 2016, 17(1): 26-34.
[24]
Rac MW, Dashe JS, Wells CE, et al. Ultrasound predictors of placental invasion: the placenta accreta index[J]. Am J Obstet Gynecol, 2015, 212(3): 343. e1-e7.
[25]
Aitken K, Allen L, Pantazi S, et al. MRI significantly improves disease staging to direct surgical planning for abnormal invasive placentation: a single centre experience[J]. J Obstet Gynaecol Can, 2016, 38(3): 246-251. e1.
[26]
Main EK, Goffman D, Seavone BM, et al. National Partnership for Maternal Safety: consensus bundle on obstetric hemorrhage[J]. Obstet Gynecol, 2015, 126(1): 155-162.
[1] 陆婷, 范晴敏, 王洁, 万晓静, 许春芳, 董凤林. 超声引导下经皮穿刺置管引流对重症急性胰腺炎的疗效及应用时机的选择[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 511-516.
[2] 张舒沁, 陈练. 产后宫腔内妊娠物残留的诊断和临床处理[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 493-497.
[3] 李霞林, 贺芳. 产后出血风险评估和早期预警系统[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 498-503.
[4] 刘子洋, 崔俭俭, 赵茵. 产科弥散性血管内凝血及其评分系统的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 511-518.
[5] 曾凡英, 阮洁, 刘兴会, 何国琳. 新生育形势下的围产医学研究现状及孕期保健中的应对策略[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 519-524.
[6] 李小飞, 刘洪莉, 石丘玲, 田静, 李莉, 漆洪波, 罗欣. 自然分娩产妇低强度聚焦超声子宫复旧治疗防治产后出血的前瞻性随机对照研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 534-539.
[7] 姚金含, 王伟娜, 张玉泉. 妊娠相关深静脉血栓形成患者的预后研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 367-373.
[8] 邢颖, 程石. 巨脾外科治疗现状与介入治疗序贯手术策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 253-258.
[9] 唐必英, 李钢. 治疗时机对动脉瘤性蛛网膜下腔出血患者预后的影响[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 213-219.
[10] 杨金朔, 吴桥伟, 王春雷, 史怀璋. 脑血管内支架成形术后再狭窄的研究进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(03): 174-179.
[11] 牟超鹏, 宗斌, 刘奕, 史美英, 徐杜娟, 冯春光. 经远端桡动脉与经常规桡动脉行急诊冠脉介入诊疗后穿刺部位血肿的对比[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 275-282.
[12] 陈芳, 王建英, 曹建用, 刘丽, 罗晓琴. 基于分析-设计-开发-实施-评价模式的叙事护理培训在产科预防性介入治疗中的应用[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 392-396.
[13] 李超迪, 刘娟芳, 闫肃, 秦胜东, 张镐哲, 常琼方, 韩新巍, 张建好. 血管性介入治疗在宫颈癌大出血患者中的临床疗效[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 217-220.
[14] 周宝林, 刘曦, 谌浩, 王金, 马雪琴. 温敏水凝胶在血管内栓塞治疗中的研究进展[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 244-249.
[15] 周洪千, 张煜坤, 顾天舒, 胡苏涛, 姜超, 张雪, 张昊, 陶华岳, 刘行, 刘彤, 陈康寅. 既往出血性脑卒中患者行经皮冠脉介入治疗后不良事件的危险因素分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 323-329.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?